BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31561205)

  • 1. Changes of serum lipopolysaccharide, inflammatory factors, and cecal microbiota in obese rats with type 2 diabetes induced by Roux-en-Y gastric bypass.
    Wu J; Zhang PB; Ren ZQ; Zhou F; Hu HH; Zhang H; Xue KK; Xu P; Shao XQ
    Nutrition; 2019; 67-68():110565. PubMed ID: 31561205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes.
    Liu H; Zhang H; Wang X; Yu X; Hu C; Zhang X
    Surg Obes Relat Dis; 2018 May; 14(5):584-593. PubMed ID: 29459013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
    Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
    J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Sprague-Dawley Rats.
    Shao Y; Ding R; Xu B; Hua R; Shen Q; He K; Yao Q
    Obes Surg; 2017 Feb; 27(2):295-302. PubMed ID: 27440168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Contribution to Weight-Independent Glycemic Improvements after Gastric Bypass Surgery.
    Hankir MK; Kovatcheva-Datchary P; Springer R; Hoffmann A; Vogel J; Seyfried F; Arora T
    Microbiol Spectr; 2023 Jun; 11(3):e0510922. PubMed ID: 37022171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-Regulation of Renal Gluconeogenesis in Type II Diabetic Rats Following Roux-en-Y Gastric Bypass Surgery: A Potential Mechanism in Hypoglycemic Effect.
    Wen Y; Lin N; Yan HT; Luo H; Chen GY; Cui JF; Shi L; Chen T; Wang T; Tang LJ
    Obes Facts; 2015; 8(2):110-24. PubMed ID: 25832593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass increases hepatic and peripheral insulin sensitivity in rats with type 2 diabetes mellitus.
    He B; Chen L; Yu C; Piao D; Wang Y; Han P
    Surg Obes Relat Dis; 2014; 10(3):485-93. PubMed ID: 24503104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of obestatin in Roux-en-Y gastric bypass surgery in the obese, type 2 diabetes Zucker rat.
    Xu X; Wang J; Li L; Wang C; Li W; Zhang Q; Yang L
    Diabetes Res Clin Pract; 2016 Sep; 119():57-64. PubMed ID: 27449711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission.
    Murphy R; Tsai P; Jüllig M; Liu A; Plank L; Booth M
    Obes Surg; 2017 Apr; 27(4):917-925. PubMed ID: 27738970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of Serum Uric Acid Level and Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in a Hyperuricemic Rat Model.
    Lu C; Li Y; Li L; Kong Y; Shi T; Xiao H; Cao S; Zhu H; Li Z; Zhou Y
    Obes Surg; 2020 May; 30(5):1799-1807. PubMed ID: 32124218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between gut microbiota and type 2 diabetic erectile dysfunction in Sprague-Dawley rats.
    Li H; Qi T; Huang ZS; Ying Y; Zhang Y; Wang B; Ye L; Zhang B; Chen DL; Chen J
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):523-530. PubMed ID: 28786059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roux-en-Y gastric bypass decreases endotoxemia and inflammatory stress in association with improvements in gut permeability in obese diabetic rats.
    Guo Y; Liu CQ; Liu GP; Huang ZP; Zou DJ
    J Diabetes; 2019 Oct; 11(10):786-793. PubMed ID: 30714321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of distal-ileal exclusion after Roux-en-Y gastric bypass on glucose tolerance and GLP-1 response in type-2 diabetes Sprague-Dawley rat model.
    Dolo PR; Li C; Zhu X; Yao L; Meng S; Hong J
    Surg Obes Relat Dis; 2018 Oct; 14(10):1552-1560. PubMed ID: 30122358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: Increased diversity and associations of discriminant genera with metabolic changes.
    Guo Y; Liu CQ; Shan CX; Chen Y; Li HH; Huang ZP; Zou DJ
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27572277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass.
    Arora T; Seyfried F; Docherty NG; Tremaroli V; le Roux CW; Perkins R; Bäckhed F
    ISME J; 2017 Sep; 11(9):2035-2046. PubMed ID: 28524868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia remission after Roux-en-Y gastric bypass: Implicated to altered monocyte inflammatory response in type 2 diabetes rats.
    Li M; Zhao Y; Zhang B; Wang X; Zhao T; Zhao T; Ren W
    Peptides; 2022 Dec; 158():170895. PubMed ID: 36240981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genus Sutterella is a potential contributor to glucose metabolism improvement after Roux-en-Y gastric bypass surgery in T2D.
    Wang C; Zhang H; Liu H; Zhang H; Bao Y; Di J; Hu C
    Diabetes Res Clin Pract; 2020 Apr; 162():108116. PubMed ID: 32194221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Braun gastrointestinal bypass surgery exerts similar hypoglycemic effects, with minimal operation time and earlier functional recovery, than Roux-en-Y bypass in type 2 diabetic rats.
    Sun W; Dai X; Li J; Li S
    Obes Surg; 2014 Feb; 24(2):171-8. PubMed ID: 24178369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics.
    Rossi I; Omotosho P; Poirier J; Spagnoli A; Torquati A
    Surgery; 2021 Mar; 169(3):539-542. PubMed ID: 33168209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.
    Monte SV; Caruana JA; Ghanim H; Sia CL; Korzeniewski K; Schentag JJ; Dandona P
    Surgery; 2012 Apr; 151(4):587-93. PubMed ID: 22088821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.